# EDGAR Filing Document

**Accession Number:** 0001591556
**File Stem:** 0001591556-23-000012
**Filing Date:** 2023-3
**Character Count:** 7600
**Document Hash:** 53a4d294967bd3f75a1f1c7848a570c4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001591556-23-000012.hdr.sgml**: 20230303

**ACCESSION NUMBER**: 0001591556-23-000012

**CONFORMED SUBMISSION TYPE**: 40-17F2

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230303

**DATE AS OF CHANGE**: 20230303

**EFFECTIVENESS DATE**: 20230303

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Investment Funds II, Inc.
- **CENTRAL INDEX KEY:** 0001591556
- **IRS NUMBER:** 464470069
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 40-17F2
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22912
- **FILM NUMBER:** 23703008

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus BNY Mellon Funds, Inc.
- **DATE OF NAME CHANGE:** 20131108
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Investment Funds II, Inc.
- **CENTRAL INDEX KEY:** 0001591556
- **IRS NUMBER:** 464470069
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 40-17F2

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus BNY Mellon Funds, Inc.
- **DATE OF NAME CHANGE:** 20131108

```

      Report of Independent Registered Public
Accounting Firm
The Board of Directors of
BNY Mellon Investment Funds II, Inc.:

We have examined management of BNY Mellon
Investment Funds II, Inc's assertion, included in the
accompanying Management Statement Regarding
Compliance With Certain Provisions of the Investment
Company Act of 1940, that BNY Mellon Alternative
Diversifier Strategies Fund, BNY Mellon Global Emerging
Markets Fund, and BNY Mellon Yield Enhancement
Strategy Fund (collectively the "Funds"), each a series of
BNY Mellon Investment Funds II, Inc., complied with the
requirements of subsections (b) and (c) of Rule 17f-2 under
the Investment Company Act of 1940 (the Act) (the
specified requirements) as of October 31, 2022. BNY
Mellon Investment Funds II, Inc's management is
responsible for its assertion. Our responsibility is to express
an opinion on management's assertion about the Funds'
compliance with the specified requirements based on our
examination.

Our examination was conducted in accordance with
attestation standards established by the AICPA. Those
standards require that we plan and perform the examination
to obtain reasonable assurance about whether
management's assertion about compliance with the
specified requirements is fairly stated, in all material
respects. An examination involves performing procedures
to obtain evidence about whether management's assertion
is fairly stated in all material respects. The nature, timing,
and extent of the procedures selected depend on our
judgement, including an assessment of the risks of material
misstatement of management's assertion, whether due to
fraud or error. We believe that the evidence we obtained is
sufficient and appropriate to provide a reasonable basis for
our opinion.
We are required to be independent and to meet our other
ethical responsibilities in accordance with relevant ethical
requirements related to the engagement.
Included among our procedures were the following tests
performed as of October 31, 2022, and with respect to
agreement of security purchases and sales, for the period
from August 31, 2022 (the date of the Funds' last
examination) through October 31, 2022:
1.	Confirmation with the Custodian of all securities held,
hypothecated, pledged or placed in escrow or out for
transfer with brokers, pledgees or transfer agents, if any;
2.	Obtained the Custodian reconciliation of security positions
held by institutions in book entry form (e.g., the Federal
Reserve Bank, The Depository Trust Company and various
sub-custodians) to Custodian records and verified that
reconciling items were cleared in a timely manner;

3.	Reconciliation of the Funds' securities per the books and
records of the Funds to those of the Custodian;
4.	Agreement of pending purchase and sale activity for the
Funds as of October 31, 2022, if any, to documentation of
corresponding subsequent bank statements;

5.	Agreement of five security purchases and five security
sales or maturities since the date of the last examination,
from the books and records of each fund to corresponding
bank statements;

6.	Confirmation of all repurchase agreements with
broker(s)/bank(s) and/or agreement of corresponding
subsequent cash receipts to bank statements and agreement
of underlying collateral with the Custodian records, if any;

7.	Review of the BNY Mellon Asset Servicing Custody and
Securities Lending Services Service Organization Control
Report ("SOC 1 Report") for the period October 1, 2021 -
September 30, 2022 and noted no relevant findings were
reported in the areas of Asset Custody and Trade
Settlement.

Our examination does not provide a legal determination on
the Funds' compliance with specified requirements.
In our opinion, management's assertion that the Funds
complied with the requirements of subsections (b) and (c)
of Rule 17f-2 of the Investment Company Act of 1940 as of
October 31, 2022, with respect to securities reflected in the
investment accounts of the Funds are fairly stated, in all
material respects.
This report is intended solely for the information and use of
management and The Board of Directors of BNY Mellon
Investment Funds II, Inc. and the Securities and Exchange
Commission and is not intended to be and should not be
used by anyone other than these specified parties.
      /s/ KPMG LLP
New York, New York
March 3, 2023

						March 3, 2023
Management Statement Regarding Compliance With
Certain Provisions of the Investment Company Act of
1940

We, as members of management of BNY Mellon
Alternative Diversifier Strategies Fund, BNY Mellon
Global Emerging Markets Fund, and BNY Mellon Yield
Enhancement Strategy Fund (collectively the "Funds"),
each a series of BNY Mellon Investment Funds II, Inc. are
responsible for complying with the requirements of
subsections (b) and (c) of Rule 17f-2, "Custody of
Investments by Registered Management Investment
Companies" of the Investment Company Act of 1940. We
are also responsible for establishing and maintaining
effective internal controls over compliance with those
requirements. We have performed an evaluation of the
Funds' compliance with the requirements of subsections (b)
and (c) of Rule 17f-2 as of October 31, 2022 and for the
period from August 31, 2022 (the date of the Funds' last
examination) through October 31, 2022.

Based on the evaluation, we assert that the Funds were in
compliance with the requirements of subsections (b) and (c)
of Rule 17f-2 of the Investment Company Act of 1940 as of
October 31, 2022, and for the period from August 31, 2022
(the date of the Funds' last examination) through October
31, 2022 with respect to securities reflected in the
investment accounts of the Funds.

BNY Mellon Investment Funds II, Inc.

Jim Windels
Treasurer

```